Company Overview
Biotronics 3D Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Thursday 29 January 2004, so this is a well established company. Biotronics 3D Limited has been in business for 22 years and 2 months. The accounts status is small and the accounts are next due on Wednesday 30 September 2026.
Registered Address

10 Upper Berkeley St, London, W1H 7PE
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameBIOTRONICS 3D LIMITED
Company Number05029338
Registered Office Address10 Upper Berkeley St
 W1H 7PE
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date29/01/2004
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategorySMALL
Returns Next Due Date26/02/2017
Returns Last Made Up Date29/01/2016
Directors & Members
Show Resigned
Brian Cole - Director
(British, 57 years old, born January 1969)
Appointed 17 December 2021
 Active
Edward Radkiewicz - Director
(British, 65 years old, born December 1961)
Appointed 17 December 2021
 Active
Secretaries
Show Resigned
Other Company Directorships
Brian Cole
31 ADELAIDE CRESCENT LIMITED
ACTIVE HEALTH PARTNERS LIMITED
ALMCOR (RW HOLDCO) LIMITED
ALMCOR (RW INTERMEDIATE) LIMITED
ALMCOR (RW YORK) LIMITED
ALMCOR (SPENDARRY) LIMITED
ALMCOR ISF LIMITED
ATTENDANCE MANAGER LTD
DOCTORLINK INNOVATIONS LIMITED
DOCTORLINK LIMITED
GOODSHAPE UK GROUP LIMITED
GOODSHAPE UK LIMITED
HEALTHHERO GROUP LIMITED
HEALTHHERO INTEGRATED CARE LIMITED
HEALTHHERO SERVICES LIMITED
HEALTHHERO SOLUTIONS LIMITED
HEALTHHERO TECHNOLOGIES LIMITED
LISBURN SQUARE NO.2 LIMITED
MEDSOL HOLDING NO. 1 LTD
MEDSOL HOLDING NO. 2 LTD
MEDTOP DOCTORLINK LIMITED
MEDTOP INTERMEDIATE LIMITED
MEDTOP MEDVIVO LIMITED
MEDTOP VALIDIUM LIMITED
MYFIRSTCARE LIMITED
OPENRAD SERVICES UK LIMITED
RE SERVICED OFFICES II LIMITED
REMEDIO SYSTEMS DEVELOPMENT LIMITED
SOFIA MEDICAL LIMITED
THE VALIDIUM GROUP LIMITED
VALIDIUM HEALTH LIMITED
VALIDIUM INTERNATIONAL LIMITED
VALIDIUM LIMITED
VISBION LTD
Edward Radkiewicz
DOCTORLINK INNOVATIONS LIMITED
DOCTORLINK LIMITED
HEALTHHERO GROUP LIMITED
HEALTHHERO INTEGRATED CARE LIMITED
HEALTHHERO SERVICES LIMITED
HEALTHHERO TECHNOLOGIES LIMITED
MEDSOL HOLDING NO. 1 LTD
MEDSOL HOLDING NO. 2 LTD
MEDTOP DOCTORLINK LIMITED
MEDTOP INTERMEDIATE LIMITED
MEDTOP MEDVIVO LIMITED
MEDTOP VALIDIUM LIMITED
VISBION LTD
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Balance Sheet
Fixed Assets 46,908 46,908 15,718
Current Assets 2,617,645 2,617,645 2,179,885
Creditors Due Within One Year 1,393,155 1,393,155 317,833
Working Cap 1,224,490 1,224,490 1,862,052
Total Assets Less Current Liabilities 1,271,398 1,271,398 1,877,770
Long-term Liabilities 0 0 0
Net Assets 1,271,398 1,271,398 1,877,770
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 1,271,398 1,271,398 1,877,770
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Tangible Fixed Assets - - -
Fixed Assets 1.8% 1.8% 0.7%
Stocks Inventory - - -
Debtors 45.6% 45.6% 32.9%
Cash Bank In Hand 52.7% 52.7% 66.4%
Current Assets 98.2% 98.2% 99.3%
Creditors Due Within One Year 52.3% 52.3% 14.5%
Net Current Assets Liabilities 46.0% 46.0% 84.8%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 47.7% 47.7% 85.5%
Capital Employed - - -
Total Assets Less Current Liabilities 47.7% 47.7% 85.5%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Liquidity Ratio 1.9 1.9 6.9
Solvency Ratio 1.9 1.9 6.9
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 3
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 3
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Assets 2,664,553 2,664,553 2,195,603
Debt 1,393,155 1,393,155 317,833
Net Assets/Debt 1,271,398 1,271,398 1,877,770

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around W1H 7PE
SEYMOUR DEVELOPMENT LIMITED
10 Upper Berkeley Street, London, W1H 7PE
TERRINGTON PROPERTIES LIMITED
10 Upper Berkeley Street, London, W1H 7PE
CADOGAN PROPERTIES LIMITED
10 Upper Berkeley Street, London, W1H 7PE
LILLOOET-CALGARY HOLDINGS,LIMITED(THE)
12A UPPER BERKELEY STREET, LONDON, W1H 7PE
WHITMORES (EDENBRIDGE) LIMITED
Chapel House, 12a Upper Berkeley Street, London, W1H 7PE
CARRIAGE ROW LIMITED PARTNERSHIP
10 UPPER BERKELEY STREET, LONDON, W1H 7PE
MARCOL EUROPEAN MANAGEMENT LLP
10 Upper Berkeley Street, London, W1H 7PE
MARCOL HEALTHCARE INTERNATIONAL LLP
10 UPPER BERKELEY STREET, LONDON, W1H 7PE
MSF DM CO LLP
10 Upper Berkeley Street, London, W1H 7PE
MSF FILTON LLP
10 UPPER BERKELEY STREET, LONDON, W1H 7PE
Document Filings
Termination of appointment of Edward Edmund Jan Radkiewicz as a director on 7 March 2026
Termination of appointment of Brian Roy Cole as a director on 7 March 2026
Appointment of Dr Soeren Grimm as a director on 7 March 2026
Appointment of Mr David Yuuki Scheurl as a director on 7 March 2026
Registered office address changed from 10 Upper Berkeley St London W1H 7PE England to Visbion House Gogmore Lane Chertsey KT16 9AP on 11 March 2026
Confirmation statement made on 29 January 2026 with no updates
Termination of appointment of Derek Lawrence Colvin as a director on 10 February 2025
Confirmation statement made on 29 January 2025 with updates
Statement of capital following an allotment of shares on 30 September 2024
Director's details changed for Mr Edward Edmund Jan Radkiewicz on 12 August 2024
Director's details changed for Mr Brian Roy Cole on 12 August 2024
Registered office address changed from 5 Greenwich View Place London E14 9NN England to 10 Upper Berkeley St London W1H 7PE on 26 March 2024
Confirmation statement made on 29 January 2024 with updates
Director's details changed for Mr Brian Roy Cole on 20 March 2023
Director's details changed for Mr Edward Edmund Jan Radkiewicz on 20 March 2023
Confirmation statement made on 29 January 2023 with updates
Director's details changed for Mr Edward Edmund Jan Radkiewicz on 27 January 2023
Director's details changed for Mr Brian Roy Cole on 16 September 2022
Confirmation statement made on 29 January 2022 with updates
Statement of Company's objects
Particulars of variation of rights attached to shares
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free